Concepedia
Statistics
Publications
8
Citations
190
H-Index
Active since
2020
Affiliations
The University of Tokyo(Current)
St. Marianna University School of Medicine
Niigata University
Toho University
Foundation for Biomedical Research and Innovation
Kenichiro Tanabe is an author at The University of Tokyo specializing in pharmacotherapy, renal pharmacotherapy, and renal disease.
Publications per year
2020–2025
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
Shizuya Yamashita, Hidenori Arai, Hideaki Bujo et al. · Journal of Atherosclerosis and Thrombosis · 2020 · 41 citations · Full text
Medicine, Cardiology, Pharmacotherapy +17
Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)
Junji Yamauchi, Kenichiro Tanabe, Tomoo Sato et al. · Viruses · 2022 · 31 citations · Full text
Pharmacy, Pharmacotherapy, Immunotherapy +12
RAISING is a high-performance method for identifying random transgene integration sites
Yusaku Wada, Tomoo Sato, Hiroo Hasegawa et al. · Communications Biology · 2022 · 31 citations · Full text
Life Sciences, Molecular Biology, Oncology +15
Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial
Terumasa Hayashi, Shoichi Maruyama, Masaomi Nangaku et al. · Clinical Journal of the American Society of Nephrology · 2020 · 28 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
Ichiei Narita, Terumasa Hayashi, Shoichi Maruyama et al. · PLoS ONE · 2022 · 20 citations · Full text
Medicine, Hematology, Nephrology +16
1–5 of 8